Humedix Co Ltd (200670) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.037x

Based on the latest financial reports, Humedix Co Ltd (200670) has a cash flow conversion efficiency ratio of 0.037x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩9.71 Billion ≈ $6.58 Million USD) by net assets (₩265.23 Billion ≈ $179.74 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 200670 net asset quality index to measure how much of total assets are equity-financed.

Humedix Co Ltd - Cash Flow Conversion Efficiency Trend (2015–2024)

This chart illustrates how Humedix Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 200670 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.

Humedix Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Humedix Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
IKIO Lighting Limited NSE:IKIO	0.008x
Bursa De Valori Bucuresti SA RO:BVB	0.021x
SAMG Entertainment Co. Ltd. KQ:419530	-0.006x
Topco Technologies TWO:3388	0.039x
Atlantic Lithium Ltd AU:A11	-0.046x
Navkar Corporation Limited NSE:NAVKARCORP	0.015x
Boab Metals Ltd AU:BML	-0.020x
Banque nationale de Belgique Société anonyme BR:BNB	N/A

Annual Cash Flow Conversion Efficiency for Humedix Co Ltd (2015–2024)

The table below shows the annual cash flow conversion efficiency of Humedix Co Ltd from 2015 to 2024. For the full company profile with market capitalisation and key ratios, see 200670 market cap overview.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩228.53 Billion ≈ $154.87 Million	₩50.74 Billion ≈ $34.39 Million	0.222x	+42.39%
2023-12-31	₩198.06 Billion ≈ $134.22 Million	₩30.89 Billion ≈ $20.93 Million	0.156x	-43.14%
2022-12-31	₩139.11 Billion ≈ $94.27 Million	₩38.15 Billion ≈ $25.86 Million	0.274x	+80.11%
2021-12-31	₩125.99 Billion ≈ $85.38 Million	₩19.18 Billion ≈ $13.00 Million	0.152x	-23.06%
2020-12-31	₩120.07 Billion ≈ $81.37 Million	₩23.76 Billion ≈ $16.10 Million	0.198x	+60.66%
2019-12-31	₩112.10 Billion ≈ $75.97 Million	₩13.81 Billion ≈ $9.36 Million	0.123x	-45.07%
2018-12-31	₩106.13 Billion ≈ $71.93 Million	₩23.80 Billion ≈ $16.13 Million	0.224x	+176.11%
2017-12-31	₩107.92 Billion ≈ $73.13 Million	₩8.77 Billion ≈ $5.94 Million	0.081x	+16.47%
2016-12-31	₩109.11 Billion ≈ $73.94 Million	₩7.61 Billion ≈ $5.16 Million	0.070x	-34.59%
2015-12-31	₩109.80 Billion ≈ $74.41 Million	₩11.71 Billion ≈ $7.93 Million	0.107x	--

About Humedix Co Ltd

KQ:200670 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$167.30 Million

₩246.88 Billion KRW

Market Cap Rank

#17172 Global

#654 in Korea

Share Price

₩24000.00

Change (1 day)

+4.12%

52-Week Range

₩22600.00 - ₩69300.00

All Time High

₩75800.00